Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: December 22, 2020

December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial

News & Announcements 2020By Richard Mollard December 22, 2020

201222_PhaseIIbcaninetrial

Recent Articles

Aug 3, Epichem Completes OHD Technology Build
August 3, 2021
July 31, Top 20 Shareholders
August 1, 2021
July 30, Virtual Investor Briefing for August 12, 2021
July 30, 2021
July 28, Appendix 4C and Quarterly Update
July 28, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

$PAA/@PharmAust’s subsidiary @Epichem builds ‘world-first’ flow reactor to convert waste into fuel

https://stockhead.com.au/health/pharmausts-subsidiary-epichem-builds-world-first-flow-reactor-to-convert-waste-into-fuel/

Reply on Twitter 1422402739422699525 Retweet on Twitter 14224027394226995253 Like on Twitter 14224027394226995253 Twitter 1422402739422699525

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions